語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Resistance to molecular therapies fo...
~
Villanueva, Augusto.
FindBook
Google Book
Amazon
博客來
Resistance to molecular therapies for hepatocellular carcinoma
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Resistance to molecular therapies for hepatocellular carcinoma/ edited by Augusto Villanueva.
其他作者:
Villanueva, Augusto.
出版者:
Cham :Springer International Publishing : : 2017.,
面頁冊數:
xiii, 147 p. :ill., digital ;24 cm.
內容註:
Tumor Heterogeneity and Resistance to Targeted Therapies in Hepatocellular Carcinoma -- Modulating Immune Responses to Overcome Resistance in Hepatocellular Carcinoma -- Role of Tumor Microenvironment in Hepatocellular Carcinoma Resistance -- Contribution of the Cancer Stem Cell Phenotype to Hepatocellular Carcinoma Resistance -- Clinical and Preclinical Perspectives on Mechanisms of Sorafenib Resistance in Hepatocellular Carcinoma -- Radiological Assessment of Response to Palliative Treatments in Hepatocellular Carcinoma -- Sorafenib and Clinical Patterns of Resistance in hepatocellular carcinoma -- Overcoming Treatment Resistance in Hepatocellular Carcinoma: regorafenib and lessons from other malignancies.
Contained By:
Springer eBooks
標題:
Liver - Cancer -
電子資源:
http://dx.doi.org/10.1007/978-3-319-56197-4
ISBN:
9783319561974
Resistance to molecular therapies for hepatocellular carcinoma
Resistance to molecular therapies for hepatocellular carcinoma
[electronic resource] /edited by Augusto Villanueva. - Cham :Springer International Publishing :2017. - xiii, 147 p. :ill., digital ;24 cm. - Resistance to targeted anti-cancer therapeutics,v.132196-5501 ;. - Resistance to targeted anti-cancer therapeutics ;v.13..
Tumor Heterogeneity and Resistance to Targeted Therapies in Hepatocellular Carcinoma -- Modulating Immune Responses to Overcome Resistance in Hepatocellular Carcinoma -- Role of Tumor Microenvironment in Hepatocellular Carcinoma Resistance -- Contribution of the Cancer Stem Cell Phenotype to Hepatocellular Carcinoma Resistance -- Clinical and Preclinical Perspectives on Mechanisms of Sorafenib Resistance in Hepatocellular Carcinoma -- Radiological Assessment of Response to Palliative Treatments in Hepatocellular Carcinoma -- Sorafenib and Clinical Patterns of Resistance in hepatocellular carcinoma -- Overcoming Treatment Resistance in Hepatocellular Carcinoma: regorafenib and lessons from other malignancies.
This volume evaluates the clinical patterns of resistance to sorafenib, the impact of trial design in the second-line setting and the current gold standard to define radiological resistance; describes the molecular mechanisms responsible for treatment resistance in HCC patients, including components of the immune system and tumor microenvironment; determines the role of the cancer stem cell phenotype in resistance; reviews the experimental models to study resistance; and addresses new approaches to overcome resistance to sorafenib, using successful examples from other malignancies.
ISBN: 9783319561974
Standard No.: 10.1007/978-3-319-56197-4doiSubjects--Topical Terms:
3250223
Liver
--Cancer
LC Class. No.: RC280.L5
Dewey Class. No.: 616.99436061
Resistance to molecular therapies for hepatocellular carcinoma
LDR
:02354nmm a2200325 a 4500
001
2105407
003
DE-He213
005
20170717181551.0
006
m d
007
cr nn 008maaau
008
180417s2017 gw s 0 eng d
020
$a
9783319561974
$q
(electronic bk.)
020
$a
9783319561967
$q
(paper)
024
7
$a
10.1007/978-3-319-56197-4
$2
doi
035
$a
978-3-319-56197-4
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC280.L5
072
7
$a
MJCL
$2
bicssc
072
7
$a
MED062000
$2
bisacsh
082
0 4
$a
616.99436061
$2
23
090
$a
RC280.L5
$b
R433 2017
245
0 0
$a
Resistance to molecular therapies for hepatocellular carcinoma
$h
[electronic resource] /
$c
edited by Augusto Villanueva.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2017.
300
$a
xiii, 147 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
Resistance to targeted anti-cancer therapeutics,
$x
2196-5501 ;
$v
v.13
505
0
$a
Tumor Heterogeneity and Resistance to Targeted Therapies in Hepatocellular Carcinoma -- Modulating Immune Responses to Overcome Resistance in Hepatocellular Carcinoma -- Role of Tumor Microenvironment in Hepatocellular Carcinoma Resistance -- Contribution of the Cancer Stem Cell Phenotype to Hepatocellular Carcinoma Resistance -- Clinical and Preclinical Perspectives on Mechanisms of Sorafenib Resistance in Hepatocellular Carcinoma -- Radiological Assessment of Response to Palliative Treatments in Hepatocellular Carcinoma -- Sorafenib and Clinical Patterns of Resistance in hepatocellular carcinoma -- Overcoming Treatment Resistance in Hepatocellular Carcinoma: regorafenib and lessons from other malignancies.
520
$a
This volume evaluates the clinical patterns of resistance to sorafenib, the impact of trial design in the second-line setting and the current gold standard to define radiological resistance; describes the molecular mechanisms responsible for treatment resistance in HCC patients, including components of the immune system and tumor microenvironment; determines the role of the cancer stem cell phenotype in resistance; reviews the experimental models to study resistance; and addresses new approaches to overcome resistance to sorafenib, using successful examples from other malignancies.
650
0
$a
Liver
$x
Cancer
$x
Chemotherapy.
$3
3250223
650
0
$a
Drug resistance in cancer cells.
$3
658434
650
1 4
$a
Biomedicine.
$3
890831
650
2 4
$a
Cancer Research.
$3
891172
700
1
$a
Villanueva, Augusto.
$3
3250221
710
2
$a
SpringerLink (Online service)
$3
836513
773
0
$t
Springer eBooks
830
0
$a
Resistance to targeted anti-cancer therapeutics ;
$v
v.13.
$3
3250222
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-56197-4
950
$a
Biomedical and Life Sciences (Springer-11642)
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9321939
電子資源
11.線上閱覽_V
電子書
EB RC280.L5
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入